FOXO TECHNOLOGIES INC. Depreciation
FOXO TECHNOLOGIES INC. (FOXO) reported Depreciation of $100.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-04-15
- FOXO TECHNOLOGIES INC. depreciation for the quarter ending 2024-12-31 was $76.00K, a 2810.76% increase year-over-year.
- FOXO TECHNOLOGIES INC. depreciation for the quarter ending 2024-09-30 was $17.00K, a 240.00% increase year-over-year.
- FOXO TECHNOLOGIES INC. depreciation for the quarter ending 2024-06-30 was $4.00K, a 55.56% decline year-over-year.
- FOXO TECHNOLOGIES INC. depreciation for the quarter ending 2023-12-31 was $2.61K, a 99.80% decline year-over-year.
- FOXO TECHNOLOGIES INC. depreciation for fiscal 2025 was $100.00K, a 0.00% change from fiscal 2024.
- FOXO TECHNOLOGIES INC. depreciation for fiscal 2024 was $100.00K, a 290.46% increase from fiscal 2023.
- FOXO TECHNOLOGIES INC. depreciation for fiscal 2023 was $25.61K, a 98.28% decline from fiscal 2022.
- FOXO TECHNOLOGIES INC. depreciation for fiscal 2022 was $1.49M, a 1417.35% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-12-31 | $100.00K 10-K · filed 2026-04-15 | |||
| 2024-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $93.00K derived: sum of 2 quarters · filed 2026-04-15 | $97.00K derived: sum of 3 quarters · filed 2026-04-15 | $100.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $17.00K 10-Q · filed 2024-11-19 | $21.00K derived: sum of 2 quarters · filed 2024-11-19 | $24.00K 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $4.00K 10-Q · filed 2024-08-19 | $7.00K 10-Q · filed 2024-08-19 | ||
| 2023-12-31 | $2.61K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $7.61K derived: sum of 2 quarters · filed 2025-04-15 | $16.61K derived: sum of 3 quarters · filed 2025-04-15 | $25.61K 10-K · filed 2025-04-15 |
| 2023-09-30 | $5.00K 10-Q · filed 2024-11-19 | $14.00K derived: sum of 2 quarters · filed 2024-11-19 | $23.00K 10-Q · filed 2024-11-19 | $2.27M derived: sum of 4 quarters · filed 2024-11-19 |
| 2023-06-30 | $9.00K 10-Q · filed 2024-08-19 | $18.00K 10-Q · filed 2024-08-19 | $2.27M derived: sum of 3 quarters · filed 2024-08-19 | |
| 2023-03-31 | $929.00K 10-Q · filed 2023-05-11 | $2.26M derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2022-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.49M 10-K · filed 2023-03-31 | ||
| 2022-09-30 | $159.00K 10-Q · filed 2022-11-21 | |||
| 2022-03-31 | $31.00K 10-Q · filed 2023-05-11 | $58.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $98.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | $71.00K 10-Q · filed 2022-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |